Per Richard Torbjörn Hallberg

Per Richard Torbjörn Hallberg is currently Director at Takeda Oy since 2016, Director at Dova Pharmaceuticals, Inc. since 2019, Director at Swedish Orphan Biovitrum, Inc., Director at Swedish Orphan Biovitrum (Belgium) SARL since 2021, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB since 2018.
Former roles include Senior Associate at Advokatfirman Lindahl KB from 1997 to 2001, Corporate Counsel at Ferring Pharmaceuticals, Inc. from 2001 to 2004, Corporate Counsel at Nycomed AB from 2004 to 2010, and Vice President & General Counsel-Emerging Markets at Takeda AB from 2015 to 2017.
Education includes graduate studies at the University of Lund.